Advisor Group’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $1K | Sell |
225
-82
| -27% | -$364 | ﹤0.01% | 5087 |
|
|
2019
Q3 | $0 | Hold |
307
| – | – | ﹤0.01% | 5302 |
|
|
2019
Q2 | $2K | Sell |
307
-15
| -5% | -$98 | ﹤0.01% | 4968 |
|
|
2019
Q1 | $2K | Hold |
322
| – | – | ﹤0.01% | 4946 |
|
|
2018
Q4 | $2K | Sell |
322
-172
| -35% | -$1.07K | ﹤0.01% | 4810 |
|
|
2018
Q3 | $6K | Buy |
494
+281
| +132% | +$3.41K | ﹤0.01% | 4505 |
|
|
2018
Q2 | $3K | Hold |
213
| – | – | ﹤0.01% | 4547 |
|
|
2018
Q1 | $1K | Buy |
213
+16
| +8% | +$75 | ﹤0.01% | 4811 |
|
|
2017
Q4 | $2K | Sell |
197
-488
| -71% | -$4.95K | ﹤0.01% | 4686 |
|
|
2017
Q3 | $8K | Buy |
685
+144
| +27% | +$1.68K | ﹤0.01% | 4079 |
|
|
2017
Q2 | $9K | Sell |
541
-267
| -33% | -$4.44K | ﹤0.01% | 3974 |
|
|
2017
Q1 | $11K | Buy |
808
+397
| +97% | +$5.41K | ﹤0.01% | 3727 |
|
|
2016
Q4 | $5K | Sell |
411
-281
| -41% | -$3.42K | ﹤0.01% | 3934 |
|
|
2016
Q3 | $12K | Buy |
692
+81
| +13% | +$1.41K | ﹤0.01% | 3450 |
|
|
2016
Q2 | $7K | Buy |
+611
| New | +$7K | ﹤0.01% | 3633 |
|